Deribe Setie Aragaw

Deribe Aragaw practices at University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System.

Deribe Aragaw's NPI, 1083147516, was assigned on April 11, 2017. Deribe Aragaw holds Maryland license D88979.

Deribe Aragaw's primary practice is University of Maryland Baltimore Washington Medical Center, at 301 Hospital Drive, Glen Burnie, MD 21061 in Anne Arundel County. The practice phone is (410) 595-1967.

Deribe Aragaw's primary practice is University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System. Deribe Aragaw is also affiliated with TidalHealth Peninsula Regional. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Deribe Aragaw to 7 more hospitals and 13 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Deribe Aragaw practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Deribe Aragaw's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Deribe Aragaw's licenses on file in 2 states: Maryland and Indiana.

CMS data shows 1,488 Medicare services from Deribe Aragaw across 5 procedure codes in 2024, for 707 Medicare patients. Medicare paid $122,559 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 707 Medicare patients who saw Deribe Aragaw in 2024. The largest group is 75 to 84, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Deribe Aragaw's median patient age at 73, with 51% women.

In 2024, Deribe Aragaw wrote 340 Medicare Part D claims for 184 patients. 93% of them were for generic drugs. CMS names the drug for 128 of them, across 7 drugs with 11 or more claims each, at $653 in total drug cost. In 2023, CMS named 97 claims across 6 drugs.

CMS Open Payments shows 47 general payments to Deribe Aragaw from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $490.